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http://dxObjective: Open surgical replacement of the whole aorta in mega aorta syndrome remains a surgical challenge.
We report our experience in the treatment of patients with mega aorta syndrome using a 3-stage hybrid repair.
Methods: From January 2006 to December 2011, 12 patients with mega aorta syndrome underwent total
replacement of the aorta with a 3-stage hybrid repair, consisting of total replacement of the arch (first stage),
retrograde revascularization of the visceral vessels (second stage), and deployment of an endograft (third stage).
The intraoperative, early (30-day), and follow-up results were analyzed.
Results: No intraoperative mortality occurred in any of the open or endovascular procedures. After the first
stage, 1 patient died, resulting in a 30-day mortality of 8.3%. After the second stage, the overall major morbidity
was 27.3% (1 surgical revision and 2 temporary dialysis treatments). After the third stage, no conversion or ma-
jor complication was recorded. The overall mean follow-up period was 31.9 months (range, 1-60 months). One
patient died at 10 months postoperatively, and another patient required adjunctive implantation of a stent graft
for a type III endoleak. At 3 years, the estimated survival, freedom from any device-related reinterventions, and
freedom from type I endoleak was 83.3%, 77.9%, and 100%, respectively.
Conclusions: Our hybrid 3-stage approach seems to be effective in the treatment of mega aorta syndrome. The
second stage was affected by non-negligible rates of perioperative complications. The overall mid-term results
were encouraging, although a larger sample size with longer follow-up is needed to compare this technique with
others. (J Thorac Cardiovasc Surg 2013;145:S171-7)Multilevel aneurysmal aortic disease is a well-recognized
condition.1 Sometimes, the whole aorta, from the coronary
artery ostia to the iliac bifurcation, is involved in the aneu-
rysmal disease. This condition has been described as mega
aorta syndrome (MAS).2
Open surgical replacement of thewhole aorta is a surgical
challenge. The substitution of the aorta during a single op-
eration has been described in only a few reports.2,3 The need
to minimize the perioperative mortality and morbidity rates
has encouraged many surgeons to investigate less-invasive
techniques. Borst and colleagues4 first described the ele-
phant trunk technique, consisting of a 2-stage open repair.
Crawford and colleagues2 treated most of their patients
with MAS using 2 to 3 open surgical steps. Recently,
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The Journal of Thoracic and Cardconsisting of a total arch replacement (stage I elephant
trunk) followed by a hybrid open or endovascular repair
of the thoracoabdominal segment.
We report our experience in the treatment of patients with
MAS using a 3-stage hybrid repair, consisting of the total
replacement of the arch (first stage), retrograde revascular-
ization of the visceral vessels (second stage), and deploy-
ment of an endograft (third stage).
PATIENTS AND METHODS
Patients
From January 2006 to December 2011, we treated 96 patients with mul-
tilevel aneurysmal aortic disease. Of these, 12 patients with MAS under-
went total replacement of the aorta with a 3-stage hybrid repair. All data
concerning these interventions were prospectively collected in a dedicated
database with about 80 fields, including demographic data, preoperative
risk factors, clinical and diagnostic preoperative assessments, intraopera-
tive features, and early (30-day) and follow-up results. All patients gave
their written consent to the procedures, which were approved by the ethics
committee. The first 2 stages were performed in the operating room, and the
last endovascular stage was performed in the angiographic suite (Figure 1).
First Stage
The first stage has been described in a previous report.6 After induction
of general anesthesia with endotracheal intubation, a transesophageal
probe was inserted and transesophageal echocardiography monitoring
was performed in all patients. Surgical repair was performed through a me-
dian sternotomy with the extension of the incision along the medial border
of the left sternocleidomastoidmuscle to better expose the supra-aortic ves-
sels. After full intravenous anticoagulation, the brachiocephalic trunk was
directly cannulated or exposed through a small right infraclaviculariovascular Surgery c Volume 145, Number 3S S171
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MAS ¼ mega aorta syndrome
TAAA ¼ thoracoabdominal aortic aneurysm72 Theincision using an 8-mm Dacron tube graft. Extracorporeal circulation and
systemic cooling were started after cannulation of the right atrium with
a standard 2-stage venous cannula, and the heart was vented through the
right superior pulmonary vein. The left subclavian artery was then detached
from the aortic arch and anastomosed end-to-end to an 8-mm Dacron tube
graft connected to a separate low flow (10mL/kg/min) perfusion line. Next,
the ascending aorta was crossclamped. Myocardial protection was
achieved using intracoronary infusion of cold (5C-8C) crystalloid cardi-
oplegia (Custodiol; Koehler Chemie, Alsbach-Haenlein, Germany). The
proximal supracoronary aortic anastomosis was performed with 4-0 mono-
filament sutures using the Lupiae graft (Vascutek Terumo Inc, Inchinnan,
Scotland), constructed with a standard cylindrical Dacron graft, with a tri-
furcated graft of different sizes (10, 10, and 8 mm) and another side branch
of 10 mm coming off the main body of the prosthesis.7
After completion of the proximal anastomosis and achievement of
moderate systemic hypothermia (26C-28C), distal aortic flow was dis-
continued, and selective antegrade cerebral protection was begun, with
a flow rate of about 10 mL/kg/min to maintain an arterial pressure in the
right radial artery of 40 to 60 mm Hg. The distal anastomosis was per-
formed on the aortic arch, preferring the space between the left carotid ar-
tery and left subclavian artery, with 4-0 monofilament sutures. The aortic
crossclamp was released, and perfusion of the heart and distal thoracic
aorta was guaranteed by connecting the arterial line with the lateral
10-mm Dacron branch of the Lupiae graft. Next, the left carotid artery
and thereafter the brachiocephalic trunk were anastomosed to the bovine
trunk-like side branch (8 and 10 mm, respectively) of the Lupiae graft.
Finally, after rewarming and removing extracorporeal circulation, the
10-mm side lateral branch of the Lupiae graft used for arterial systemic
perfusion was anastomosed to the Dacron graft used for selective perfusion
of the left subclavian artery (Figure 2, A).
Second Stage
With the patient under general anesthesia and in the supine position,
a midline laparotomy was performed. The abdominal aorta, common iliac
arteries, and initial portion of the celiac trunk, superior mesenteric artery,
and renal arteries were exposed. The Lupiae graft or a similar multi-
branched graft was used for visceral vessel debranching. After intravenous
anticoagulation, the abdominal aorta was crossclamped and replaced using
the main body of the multibranched Dacron graft, using 4-0 monofilament
sutures (Figure 2, B).
The side branches were distally anastomosed to the visceral vessels in
a retrogrademanner. In all reconstructions, the visceral vessels were ligated
proximally to prevent retrograde perfusion of the aneurysmal sac. For renal
revascularization, diuresis was forced by systemic infusion of furosemide.
During renal artery crossclamping, a continuous perfusion of approxi-
mately 500 mL of cold (4C) crystalloid lactated Ringer’s solution was ad-
ministered into the orifice of the renal artery to reduce the temperature of
the kidney (to 15C-18C). For celiac trunk revascularization, the graft
was routed in front of the left renal vein behind the pancreas. The superior
mesenteric artery was anastomosed in a lazy-C fashion to avoid kinking. In
all cases, the inferior mesenteric artery was reimplanted. All visceral anas-
tomoses were performed in an end-to-side fashion (with the exception of
the celiac trunk, which was anastomosed end-to-end) using 5-0 monofila-
ment sutures. A final sequential declamping was performed. The grafts
were then covered with retroperitoneum whenever possible.Journal of Thoracic and Cardiovascular SurThird Stage
The endovascular step was performed with the patient under locore-
gional anesthesia. One of the common femoral arteries was surgically
exposed. The contralateral femoral artery was cannulated with a percutane-
ous puncture. The first step consisted of positioning a 0.035-in. guidewire
(Terumo, Terumo Medical Corp, Tokyo, Japan) for the insertion of a 5F
short sheath using the percutaneous approach. Next, a 5F pigtail catheter
(Cordis Corp, Miami, Fla) was positioned immediately above the ostia of
the coronary arteries. An intraoperative angiogram with nonionic contrast
medium was performed to visualize the proximal radiopaque markers of
the Lupiae graft.
Through the surgical access site, using a 260-cm Lunderquist stiff wire
(Cook Inc, Bloomington, Ind), the stent graft with its delivery system was
advanced. The image intensifier was positioned at the base of the aortic
arch to obtain the optimal angle for deploying the graft. When the proximal
radiopaque markers of the Lupiae graft were visualized, delivery was per-
formed. A completion angiogram was always performed to verify immedi-
ate technical success. Then the device was removed, and the other modules
were deployed to cover the entire aorta up to the aortic anastomosis of the
visceral debranching graft, using the radiopaque marker of the Lupiae
graft. For adequate sealing of the stent graft, ballooning of the whole graft
was performed in all cases with a Reliant balloon (Medtronic Cardiovascu-
lar, Santa Rosa, Calif; Figure 2, C).
Follow-up and Statistical Analysis
All patients routinely underwent computed tomography scan at each
discharge. A computed tomography scan was then performed after the third
stage at 6 and 12 months postoperatively and yearly thereafter. Statistical
analysis was performed using SPSS, version 15.0, for Windows (SPSS
Inc, Chicago, Ill). Continuous data are expressed as the mean range. Cat-
egorical data are expressed as percentages. Follow-up data in terms of sur-
vival, freedom from any device-related reintervention, and freedom from
type I endoleak were analyzed using life-table analysis (Kaplan-Meier
test).
RESULTS
Preoperative Clinical and Anatomic Features
Patient demographic data and preoperative risk factors
are summarized in Table 1. The patients were predomi-
nantly men (9/12, 75%), with a mean age of 69.1 years
(range, 28-81 years). According to the American Society
of Anesthesiologists classification, before the first proce-
dural stage, 4 patients (33.3%) were considered in class
IV. All patients had massive dilatation of the aorta; no dis-
sections were present. One young patient had Marfan syn-
drome. The mean diameter of the aorta was 66.7 mm
(range, 56-80 mm).
The intraoperative technical data from each patient at
each stage are listed in Table 2. During the first stage, 6 pa-
tients (50%) underwent concomitant aortic valve repair,
and 2 patients underwent concomitant coronary artery
bypass grafting. After each procedure, the patients were ad-
mitted to the intensive care unit.
Early Results
No intraoperativemortality occurred in any of the open or
endovascular procedures. After the first open surgical stage,
1 patient died of rupture of the descending thoracic aorta,
for an overall perioperative 30-day mortality rate of 8.3%gery c March 2013
FIGURE 1. Scheme of hybrid 3-stage repair.
Troisi et al Panel 4(1/12); no stroke, paraplegia, or reintervention occurred.
The rate of major morbidity after the first stage was 8.3%
(1 tracheostomy). The mean delay between the first and sec-
ond stage was 69.5 days (range, 49-83 days).
After the second stage, no perioperative death occurred,
but 1 patient required surgical revision for massive bleed-
ing, and 2 patients required temporary dialysis for acute re-
nal failure. The overall major morbidity rate was 27.3%
(3/11). The mean delay between the second and third stage
was 52.1 days (range, 38-61 days).
After the third endovascular stage, no surgical conversion
or major complication was recorded. Four patients (36.4%)
developed a postimplantation syndrome. The computed to-
mography scan at discharge showed the absence of migra-
tion or type I/III endoleak in all patients.Follow-up Results
Follow-up data were available for all patients, with an
overall mean duration of 31.9 months (range, 1-60 months).
The follow-up results are summarized in Table 2.
One patient died at 10 months postoperatively of acute
myocardial infarction. During the follow-up period, no
stroke, paraplegia, conversion to open repair, type I endo-
leak, or graft migration occurred. No patient required life-
long permanent dialysis. All supra-aortic branches were
patent, and 1 asymptomatic occlusion of a renal branch oc-
curred. In 1 patient, adjunctive implantation of a stent graftThe Journal of Thoracic and Cardwas necessary to correct a type III endoleak. One patient de-
veloped a median abdominal hernia that was surgically
treated at 8 months.
At 3 years, the estimated survival, freedom from any
device-related reintervention, and freedom from type I en-
doleak was 83.3%, 77.9%, and 100%, respectively
(Figure 3). Univariate analysis demonstrated that none of
the pre- or intraoperative factors significantly affected the
2-year rates of survival, freedom from any device-related
reintervention, or freedom from type I endoleak.DISCUSSION
The natural history of aortic aneurysms, regardless of eti-
ology and location, is eventual rupture. Studies from the
1970s and 1980s showed that death occurred within 5 years
in more than 75% of cases.8-10 A recent study conducted
in the modern era demonstrated that 55% of patients
with a thoracoabdominal aortic aneurysm (TAAA) and
considered unfit for surgery had died within 1 year.11
MAS is a rare condition, and no study of its natural his-
tory has been published. MAS should be considered a seri-
ous life-threatening condition, and treatment within a short
time from the diagnosis is mandatory.
The total replacement of the aorta in 1 step is a prohibitive
surgical challenge. Thus, patients with MAS must undergo
at least 2 procedures: the first to treat the aortic arch and the
descending thoracic aorta, and the second to treat theiovascular Surgery c Volume 145, Number 3S S173
FIGURE 2. Intraoperative features (A, first stage; and B, second stage) and (C) computed tomography scan at discharge (third stage).BCT,Brachiocephalic
trunk; CABG, coronary artery bypass grafting; LCA, left common carotid artery; LSA, left subclavian artery; SMA, superior mesenteric artery; CT, celiac
trunk; RRA, right renal artery; LRA, left renal artery; IMA, inferior mesenteric artery; RCIA, right common iliac artery; LCIA, left common iliac artery.
Panel 4 Troisi et althoracoabdominal aortic tract. Borst and colleagues4 in
1983 significantly changed the traditional surgical approach
to the treatment of patients with aneurysms involving both
the ascending and the descending aortic segments at the
same time. These investigators introduced the elephant
trunk technique, which involves leaving a segment of Da-
cron prosthesis in the descending aorta during the first stage,
making replacement of the aneurysmal descending aorta far
easier in the second stage. A recent meta-analysis12 showed
that the conventional elephant trunk technique resulted in
in-hospital mortality of about 10% throughout 27 years of
experience. Furthermore, this technique was accompanied
by a non-negligible rate of stroke and spinal cord ischemia
(4.6% and 2%, respectively).
Because of the need to minimize the operative risks, sev-
eral investigators investigated the applicability of endovas-
cular techniques for the treatment of the aortic arch and
descending thoracic aorta.13-18 The single-stage frozen ele-
phant trunk technique seemed to reduce the in-hospital mor-
tality (6.4%), even if the risk of stroke remained the
same (5%), with an increase in the risk of spinal cordS174 The Journal of Thoracic and Cardiovascular Surischemia.12,16 In addition, total aortic arch debranching
with subsequent standard endovascular exclusion did not
reduce the overall in-hospital mortality (8.3%) and main-
tained similar results in terms of stroke (5.8%) and spinal
cord ischemia (1.6%).12 Thus, the results of novel open
or endovascular techniques in the treatment of aneurysms
involving the aortic arch and descending thoracic aorta ap-
pear contradictory.
With regard to the thoracoabdominal aortic segment,
contemporary series showed that open repair can be
performed with satisfactory results in centers of excel-
lence.19,20 Moreover, Wong and colleagues21 demonstrated
that the results obtained in the patients treated in more re-
cent years are respectable (7.9% mortality and 2.6% para-
plegia), even when the outcomes were compared with those
obtained with the emerging novel techniques (endovascular
and hybrid).
The need to reduce the perioperative risks induced many
to investigate less-invasive techniques. Total endovascular
repair with fenestrated and branched devices represents an
innovative technique to treat TAAAs. However, it requiresgery c March 2013
TABLE 1. Demographic data and risk factors
Variable Value
Gender
Male 9 (75)
Female 3 (25)
Age (y)
Mean 69.1
Range 28-81
Smoking 9 (75)
Hypertension 11 (91.7)
Hypercholesterolemia 4 (33.3)
Diabetes mellitus 3 (25)
COPD 8 (66.7)
Chronic renal failure 2 (16.7)
Cerebrovascular disease 1 (8.3)
Coronary artery disease 7 (58.3)
Congestive heart failure 4 (33.3)
Severe aortic regurgitation 6 (50)
Chest/abdominal pain 2 (16.7)
COPD, Chronic obstructive pulmonary disease.
Troisi et al Panel 4great expertise, and places with great experience are limited
to a few centers worldwide. A recent review22 reported that
the overall 30-day mortality in 155 patients with TAAAs in-
cluded in their analysis was 7.1%. Furthermore, the rate of
permanent paraplegia or paraparesis was 3.2%. These data
are comparable, but not superior, to those obtained with
open surgical repair performed in centers of excellence.18-20
In addition, the incidence of late complications requiring
a secondary procedure was not negligible (26.2% at
a mean follow-up of 25 months).23
Hybrid 2-stage open or endovascular treatment of
TAAAs was a recent alternative approach, consisting of
the retrograde revascularization of the visceral vesselsTABLE 2. Intraoperative, early (30-day), and follow-up results
Pt.
no.
First stage Second stage
Branches
(n) Complications
Interval
between
stages (d)
Branches
(n) Complications
1 4 Tracheostomy 72 4 Temporary dialysis
2 4 68 3
3 4 70 4
4 4 Death — — —
5 4 71 2
6 4 83 4 Surgical revision for
bleeding
7 4 49 2
8 4 81 4
9 4 73 4
10 4 61 4
11 4 66 4
12 4 71 4 Temporary dialysis
Pt. No., Patient number. *Valiant is a trademark of Medtronic Cardiovascular (Santa Rosa
The Journal of Thoracic and Cardthrough a midline laparotomy, with the subsequent deploy-
ment of a standard endograft. Most published reports re-
garding this technique have been case series, with
ambiguous results. A recent meta-analysis24 showed that re-
pair of thoracoabdominal pathologic features using hybrid
procedures in patients who are poor surgical candidates is
still associated with significant morbidity and mortality.
In particular, the pooled estimate for 30-day mortality was
12.8%, and the pooled rate for irreversible paraplegia was
4.5%. Thus, also in this field, the results of innovative,
less-invasive techniques seem to be contradictory.
Our novel technique offers some news in the variegated
scenario of aortic treatment. It is a 3-stage repair that offers
the possibility of treating the whole aorta (from the coro-
nary ostia to the aortic bifurcation), combining open and en-
dovascular techniques. Replacement of the aorta was
distributed within about 3months. In our experience, no spi-
nal cord injury occurred, despite sacrifice of all intercostal
and lumbar vessels. We would attribute this to the fact
that the segmental artery sacrifice was staged, eliminating
the lumbar vessels first at the second stage and then, after
a delay, the intercostal arteries at the third stage. This has
been previously reported by Etz and colleagues25 in their
experience with the 2-stage procedure and in laboratory
studies demonstrating recovery of spinal perfusion pres-
sures within a few days of segmental vessel occlusion26 or
absence of spinal cord injury after staged hybrid lumbar
and intercostal sacrifice.27
Moreover, our technique uses an innovative multi-
branched prosthesis (Lupiae graft) designed to obtain an op-
timal Dacron landing zone of 4 to 6 cm in both the
ascending aorta (proximal) and the abdominal aorta (distal),
for easier endovascular stent graft deployment. TheThird stage Follow-up
Interval
between
stages (d) Endograft Complications
Duration
(mo) Complications
57 Valiant* 60
61 Valiant 60
46 Valiant 60
— — — 1 Death
60 Valiant 48
45 Valiant 36 Type III endoleak
38 Valiant 36
53 Valiant 24
52 Valiant 10 Death
47 E-Vitay 24 Abdominal hernia
60 Valiant 12
54 Valiant 12 Renal branch
occlusion
, Calif). yE-Vita is a trademark of Jotec (Hechingen, Germany).
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FIGURE 3. Estimated 3-year life-table analyses (Kaplan-Meier test).
Panel 4 Troisi et alpresence of radiopaque markers facilitates the release of the
stent graft in the safe area of the Dacron graft, minimizing
the risk of type I endoleak. In the present series, no patient
experienced a type I (a/b) endoleak during follow-up.
The first stage of our procedure appeared to be safe and
effective, and the results in terms of mortality (8.3%)
were comparablewith those obtained with other techniques.
In contrast, the second stage appeared to be affected by
more frequent complications, although our outcomes
seemed to be better than those reported in published studies
of hybrid treatment of TAAA. Finally, the third stage
seemed to be safe. Only 1 patient developed a type III endo-
leak during follow-up (separation between 2 modules),
probably related to the excessive length of the endograft.CONCLUSIONS
Our hybrid 3-stage approach seems to be effective in the
treatment of MAS. The second stage was affected by non-
negligible rates of perioperative complications. The overall
midterm results were encouraging, although a larger sample
size with longer follow-up is needed to compare this tech-
nique with others.References
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